Core Scientific, Inc. (CORZ) Key Metrics
CORZ valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $4.33B
- Enterprise value
- $8.34B
- P/E (TTM)
- —
- Forward P/E
- 30.7
- PEG ratio
- —
- Price / sales
- 9.8
- Price / book
- —
- EV / EBITDA
- 454.9
- Dividend yield
- —
- Beta
- 5.48
CORZ key metrics, FY2019–FY2025
Fiscal year ended September 30, 2025 · U.S. dollarsCORZ valuation Price multiples at each fiscal year-end price.
Price / sales+201.0%
17.9
FY2025 · hover or tap a bar for each year
FY2019FY2025
Free cash flow yield−6.2 pts
−7.9%
FY2025 · hover or tap a bar for each year
FY2019FY2025
CORZ returns How much profit the business earns on the capital it uses.
Return on assets+99.2 pts
−14.6%
FY2025 · hover or tap a bar for each year
FY2019FY2025
Free cash flow margin−131.1 pts
−141.3%
FY2025 · hover or tap a bar for each year
FY2019FY2025
Asset turnover−63.4%
0.16
FY2025 · hover or tap a bar for each year
FY2019FY2025
CORZ per-share figures Results divided by the shares outstanding at year-end.
Revenue per share−49.8%
$1.00
FY2025 · hover or tap a bar for each year
FY2019FY2025
Earnings per share
−$0.91
FY2025 · hover or tap a bar for each year
FY2019FY2025
Free cash flow per share
−$1.42
FY2025 · hover or tap a bar for each year
FY2019FY2025
Book value per share
−$3.03
FY2025 · hover or tap a bar for each year
FY2019FY2025
Shares outstanding+24.3%
318.1M
FY2025 · hover or tap a bar for each year
FY2019FY2025
CORZ financial health Debt, liquidity and how easily interest is covered.
Net debt+$385.4M
$748.9M
FY2025 · hover or tap a bar for each year
FY2019FY2025
Current ratio−82.9%
1.15
FY2025 · hover or tap a bar for each year
FY2019FY2025
Interest coverage
-68.5
FY2025 · hover or tap a bar for each year
FY2019FY2025
Debt / assets−39.8%
0.45
FY2025 · hover or tap a bar for each year
FY2019FY2025
CORZ efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding+191 days
193 days
FY2025 · hover or tap a bar for each year
FY2019FY2025
Days payables outstanding+13 days
94 days
FY2025 · hover or tap a bar for each year
FY2019FY2025
Cash conversion cycle+178 days
99 days
FY2025 · hover or tap a bar for each year
FY2019FY2025
Capex / revenue+209.9 pts
228.5%
FY2025 · hover or tap a bar for each year
FY2019FY2025
CORZ valuation history
Fiscal year-endToday7-year median
CORZ returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CORZ debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CORZ cash returned to shareholders
DividendsBuybacksFree cash flow
CORZ price vs earnings per share
Share price at year-endEPS (right axis)
CORZ key metrics
FY2019–FY2025| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Valuation | |||||||
| Market capitalization | $5.71B | $3.03B | — | — | — | — | — |
| Enterprise value | $6.46B | $3.40B | — | — | — | — | — |
| Price / sales | 17.9 | 5.9 | — | — | — | — | — |
| Price / operating cash flow | 20.5 | 70.7 | — | — | — | — | — |
| EV / sales | 20.2 | 6.7 | — | — | — | — | — |
| Earnings yield | −5.1% | −43.3% | — | — | — | — | — |
| Free cash flow yield | −7.9% | −1.7% | — | — | — | — | — |
| Shareholder yield (dividends + buybacks) | — | 0.0% | — | — | — | — | — |
| Share price at fiscal year-end | $17.94 | $11.86 | — | — | — | — | — |
| Per share | |||||||
| Revenue per share | $1.00 | $2.00 | $1.32 | $1.71 | $2.33 | $0.16 | $0.16 |
| Earnings per share | −$0.91 | −$5.14 | −$0.65 | −$5.72 | $0.20 | −$0.03 | −$0.03 |
| Operating cash flow per share | $0.87 | $0.17 | $0.17 | $0.55 | −$0.24 | −$0.06 | −$0.00 |
| Free cash flow per share | −$1.42 | −$0.20 | $0.13 | −$1.06 | −$0.50 | −$0.07 | −$0.10 |
| Cash per share | $0.98 | $3.27 | $0.13 | $0.04 | $0.51 | $0.02 | $0.02 |
| Book value per share | −$3.03 | −$3.21 | −$1.57 | −$1.09 | $5.75 | $0.35 | $0.36 |
| Tangible book value per share | −$3.03 | −$3.21 | −$1.58 | −$1.10 | $1.19 | $0.18 | $0.19 |
| Capex per share | $2.29 | $0.37 | $0.04 | $1.60 | $0.25 | $0.00 | $0.10 |
| Debt per share | $3.33 | $4.69 | $2.28 | — | $3.51 | $0.11 | $0.02 |
| Shares outstanding | 318.1M | 255.8M | 379.9M | 375.2M | 233.3M | 379.9M | 379.9M |
| Change in shares outstanding | +24.3% | −32.7% | +1.2% | +60.8% | −38.6% | 0.0% | — |
| Returns & profitability | |||||||
| Return on equity (ROE) | — | — | — | — | 6.4% | −9.1% | −8.8% |
| Return on invested capital (ROIC) | — | — | — | — | 11.3% | −3.3% | −6.8% |
| Return on assets (ROA) | −14.6% | −113.8% | −32.4% | −132.2% | 3.6% | −6.3% | −7.4% |
| Return on tangible assets | −12.3% | −82.2% | −34.7% | −266.3% | 3.4% | −7.6% | −11.9% |
| Free cash flow margin | −141.3% | −10.2% | 9.7% | −61.9% | −21.3% | −42.0% | −64.3% |
| Income quality (OCF / net income) | — | — | — | — | −1.20 | — | — |
| Financial health | |||||||
| Total debt | $1.06B | $1.20B | $865.5M | — | $818.8M | $40.3M | $7.5M |
| Cash & short-term investments | $311.4M | $836.2M | $50.4M | $15.9M | $117.9M | $8.7M | $6.7M |
| Net debt | $748.9M | $363.6M | $815.1M | −$15.9M | $700.9M | $31.6M | $837,000 |
| Debt / equity | — | — | — | — | 0.61 | 0.30 | 0.06 |
| Debt / assets | 0.45 | 0.75 | 1.22 | — | 0.34 | 0.18 | 0.05 |
| Net debt / EBITDA | — | — | — | — | 4.98 | 19.36 | — |
| Current ratio | 1.15 | 6.72 | 0.20 | 0.46 | 2.36 | 1.02 | 0.57 |
| Quick ratio | 1.15 | 6.72 | 0.21 | 0.46 | 2.36 | 0.18 | 0.57 |
| Interest coverage | -68.5 | -0.5 | 0.1 | -2.5 | 3.8 | -1.4 | -49.7 |
| Working capital | $114.1M | $769.4M | −$391.4M | −$101.7M | $436.3M | $1.3M | −$8.4M |
| Invested capital | −$213.8M | −$456.6M | $218.2M | −$425.2M | $2.04B | $165.3M | $136.7M |
| Tangible asset value | −$962.7M | −$820.2M | −$599.2M | −$411.1M | $277.3M | $68.8M | $73.6M |
| Net current asset value | −$2.41B | −$1.52B | −$1.21B | −$1.13B | −$341.1M | −$21.0M | −$15.1M |
| Graham number | — | — | — | — | $5.12 | — | — |
| Graham net-net per share | −$8.63 | −$6.18 | −$3.31 | −$3.20 | −$4.19 | −$0.14 | −$0.05 |
| Capital allocation | |||||||
| Share buybacks (net) | — | $0 | $31.6M | $31.6M | $0 | $0 | — |
| Dividends + buybacks / free cash flow | — | — | 64.6% | — | — | — | — |
| Capex / revenue | 228.5% | 18.6% | 3.2% | 94.0% | 10.9% | 2.6% | 62.9% |
| Capex / operating cash flow | 262.0% | 221.4% | 24.8% | 293.2% | — | — | — |
| Capex / depreciation | 9.09 | 0.79 | 0.17 | 2.66 | 1.78 | 0.17 | 6.12 |
| Stock-based compensation / revenue | 30.8% | 10.2% | 11.7% | 28.6% | 7.2% | 5.0% | 4.8% |
| R&D / revenue | — | 2.3% | 1.4% | 4.2% | 1.4% | 8.7% | 9.2% |
| SG&A / revenue | 57.2% | 23.6% | 20.1% | 35.3% | 11.9% | 24.1% | 29.5% |
| Efficiency | |||||||
| Days sales outstanding | 193.5 | 2.9 | 2.7 | 0.6 | 0.9 | 4.2 | 1.8 |
| Days of inventory on hand | — | — | -5.9 | — | — | 417.9 | — |
| Days payables outstanding | 94.4 | 81.5 | 100.4 | 18.8 | 8.8 | 37.8 | 55.9 |
| Cash conversion cycle (days) | 99.1 | -78.6 | -103.6 | -18.3 | -7.8 | 384.3 | -54.1 |
| Receivables turnover | 1.89 | 124.80 | 135.49 | 660.46 | 390.45 | 86.54 | 207.40 |
| Payables turnover | 3.87 | 4.48 | 3.64 | 19.37 | 41.65 | 9.65 | 6.53 |
| Inventory turnover | — | — | — | — | — | 0.87 | — |
| Asset turnover | 0.16 | 0.44 | 0.66 | 0.39 | 0.41 | 0.31 | 0.37 |
| Average receivables | $169.1M | $4.1M | $3.7M | $969,500 | $1.4M | $697,000 | $287,000 |
| Average payables | $72.7M | $87.0M | $104.2M | $32.6M | $7.3M | $5.3M | $7.5M |
| Average inventory | — | — | −$6.2M | — | — | $58.3M | — |
| Intangibles / total assets | 0.0% | 0.0% | 0.3% | 0.2% | 43.6% | 28.8% | 38.4% |
Computed from CORZ's annual financial statements (latest annual report filed March 2, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CORZ valuation and financial ratios
It ended the year with $1.1 billion of debt and $311.4 million in cash and short-term investments, net debt of $748.9 million. The share count fell 16.3% from 379.9M to 318.1M over 6 years.
See the CORZ income statement, the CORZ chart for price history, or the CORZ stock overview for the latest quote and news.
CORZ key metrics FAQ
How much debt does Core Scientific have?
Core Scientific had total debt of $1.1 billion at the end of fiscal 2025.
What is Core Scientific's free cash flow yield?
Core Scientific generated -$450.8 million of free cash flow in fiscal 2025, a free cash flow yield of −7.9% on its market value at year-end ($5.7 billion).
What is Core Scientific's current ratio?
Core Scientific's current ratio was 1.15 at the end of fiscal 2025: current assets were 1.15 times current liabilities.